Valganciclovir Hydrochloride

DRUG3 trials

Sponsors

Dr. Reddy's Laboratories Limited, University of California, San Francisco

Conditions

Cytomegalovirus Anterior UveitisHealthy

Phase 1

Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition

CompletedNCT02296723

Dr. Reddy's Laboratories LimitedHealthy

Start: 2011-07-31End: 2011-08-31Updated: 2014-11-20

Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition

CompletedNCT02297854

Dr. Reddy's Laboratories LimitedHealthy

Start: 2011-07-31End: 2011-08-31Updated: 2014-11-21

Phase 2

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes

TerminatedNCT03586284

University of California, San FranciscoCytomegalovirus Anterior Uveitis

Start: 2020-03-15End: 2024-11-13Updated: 2026-03-05